Cigarette Smoking Potentiates Endothelial Dysfunction of Forearm Resistance Vessels in Patients with Hypercholesterolemia Role of Oxidized LDL

Circulation

Volumn 93, Issue 7, 1996, Pages 1346-1353

  Heitzer, Thomas ^a   Ylä Herttuala, Seppo ^b   Luoma, Jukka ^b   Kurz, Sabine ^a   Münzel, Thomas ^a   Just, Hanjörg ^a   Olschewski, Manfred ^a   Drexler, Helmut ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

Endothelium lipoproteins; Hypercholesterolemia; Smoking

Indexed keywords

LOW DENSITY LIPOPROTEIN;

ADULT; ARTICLE; BLOOD VESSEL REACTIVITY; CHOLESTEROL BLOOD LEVEL; CIGARETTE SMOKING; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; LIMB BLOOD FLOW; MALE; PRIORITY JOURNAL; RESISTANCE BLOOD VESSEL; RISK FACTOR; VASCULAR ENDOTHELIUM;

ACETYLCHOLINE; ADRENERGIC ALPHA-ANTAGONISTS; ARGININE; ARTERIOSCLEROSIS; AUTOANTIBODIES; CARDIOVASCULAR DISEASES; ENDOTHELIUM, VASCULAR; FEMALE; FOREARM; HUMANS; HYPERCHOLESTEROLEMIA; LIPID PEROXIDATION; LIPOPROTEINS, LDL; MALE; MIDDLE AGED; MUSCLE, SMOOTH, VASCULAR; NITRIC OXIDE; NITROPRUSSIDE; OMEGA-N-METHYLARGININE; OXIDATION-REDUCTION; PHENTOLAMINE; RISK FACTORS; SMOKING; VASCULAR RESISTANCE; VASODILATION; VASODILATOR AGENTS; VASOMOTOR SYSTEM;

EID: 0029987050     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.93.7.1346     Document Type: Article

References (45)

1. Vane JR, Änggard EE, Botting RM. Regulatory functions of the vascular endothelium. N Engl J Med. 1990;323:27-36.
2. Creager MA, Cooke JP, Mendelsohn ME, Gallagher SJ, Coleman SM, Loscalzo J, Dzau VJ. Impaired vasodilation of forearm resistance vessels in hypercholesterolemic humans. J Clin Invest. 1990;86:228-234.
3. Drexler H, Zeiher AM, Meinzer K, Just H. Correction of endothelial dysfunction in coronary microcirculation of hypercholesterolaemic patients by L-arginine. Lancet. 1991;338:1546-1550
4. Panza JA, Quyyumi AA, Brush JE, Epstein SI. Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension. N Engl J Med. 1990;323:22-27.
5. Sackett DL, Gibson RW, Bross IDJ, Pickren JW. Relation between aortic atherosclerosis and the use of cigarettes and alcohol: an autopsy study. N Engl J Med. 1968;279:1413-1420.
6. Kannel WB. Update on the role of cigarette smoking in coronary artery disease. Am Heart J. 1981;101:319-328.
7. Nowak J, Murray JJ, Oates JA, FitzGerald GA. Biochemical evidence of a chronic abnormality in platelet and vascular function in healthy individuals who smoke cigarettes. Circulation. 1987;76: 6-14.
8. Nadler JL, Velasco JS, Horton R. Cigarette smoking inhibits prostacyclin formation. Lancet. 1983;1:1248-1250.
9. Vita JA, Treasure CB, Nabel EG, McLenachan JM, Fish RD, Yeung AC, Vekshtein VI, Selwyn AP, Ganz P. Coronary vasomotor response to acetylcholine relates to risk factors for coronary artery disease. Circulation. 1990;81:491-497.
10. Nitenberg A, Antony I, Foult J-M. Acetylcholine-induced coronary vasoconstriction in young, heavy smokers with normal coronary arteriographic findings. Am J Med. 1993;95:71-77.
11. Minor RL, Oskarsson H, Rossen JD, Winniford MD. Is coronary flow reserve reduced in chronic cigarette smokers? Circulation. 1992;86(suppl I):I-117. Abstract.
12. Celermajer DS, Sorensen KE, Georgakopoulos D, Bull C, Thomas O, Robinson J, Deanfield JE. Cigarette smoking is associated with dose-related and potentially reversible impairment of endothelium-dependent dilation in healthy young adults. Circulation. 1993;88: 2149-2155.
13. Rangemark C, Wennmalm A. Endothelium-dependent and -independent vasodilation and reactive hyperemia in healthy smokers. J Cardiovasc Pharmacol. 1992;20(suppl 12):S198-S201.
14. Jacobs M-C, Lenders JWM, Kapma JA, Smits P, Thien T. Effect of chronic smoking on endothelium-dependent vascular relaxation in humans. Clin Sci (Colch). 1993;85:51-55.
15. Cohen RA, Zitnay KM, Haudenschild CC, Cunningham LD. Loss of selective endothelial cell vasoactive functions caused by hypercholesterolemia in pig coronary arteries. Circ Res. 1988;63:903-910.
16. Verbeuren TJ, Jordaens FH, Zonnekeyn LL, Van Hove CE, Coene MC, Herman AG. Effect of hypercholesterolemia on vascular reactivity in the rabbit. Circ Res. 1986;58:552-564.
17. Galle J, Mülsch A, Busse R, Bassenge E. Effects of native and oxidized low density lipoproteins on formation and inactivation of EDRF. Arterioscler Thromb. 1991;11:198-203.
18. Minor RL Jr, Myers PR, Guerra R, Bates JN, Harrison DG. Diet-induced atherosclerosis increases the release of nitrogen oxides from rabbit aorta. J Clin Invest. 1990;86:2109-2116.
19. 2-isoprostanes) in smokers: smoking as a cause of oxidative damage. N Engl J Med. 1995;332:1198-1203.
20. Salonen JT, Ylä-Herttuala S, Yamamoto R, Butler S, Korpela H, Salonen R, Nyyssönen K, Palinski W, Witztum JL. Autoantibody against oxidised LDL and progression of carotid atherosclerosis. Lancet. 1992;339:883-887.
21. Kiowski W, Böhler FR, van Brummelen P, Amann FW. Plasma noradrenaline concentration and alpha-adrenoceptor-mediated vasoconstriction in normotensive and hypertensive man. Clin Sci (Colch). 1981;60:483-489.
22. Zeiher AM, Schächinger V, Minners J. Long-term smoking impairs endothelium-dependent coronary arterial vasodilator function. Circulation. 1995;92:1094-1100.
23. Vallance P, Collier J, Moncada S. Effects of endothelium-derived nitric oxide on peripheral arteriolar tone in man. Lancet. 1989;2: 997-1000.
24. Kiowski W, Linder L, Stoschitzky K, Pfisterer M, Burckhardt D, Burkart F, Bühler FR. Diminished vascular response to inhibition of endothelium-derived nitric oxide and enhanced vasoconstriction to exogenously administered endothelin-1 in clinically healthy smokers. Circulation. 1994;90:27-34.
25. Benowitz NL. Pharmacologic aspects of cigarette smoking and nicotine addiction. N Engl J Med. 1988;319:1318-1330.
26. Cryer PE, Haymond MW, Santiago JV, Shah SD. Norepinephrine and epinephrine release and adrenergic mediation of smoking-associated hemodynamic and metabolic events. N Engl J Med. 1976; 295:573-577.
27. Winniford MD, Wheelan KR, Kremers MS, Ugolini V, van den Berg E, Niggemann EH, Jansen DE, Hillis LD. Smoking-induced coronary vasoconstriction in patients with atherosclerotic coronary artery disease: evidence for adrenergically mediated alterations in coronary artery tone. Circulation. 1986;73:662-667.
28. Quillen JE, Rossen JD, Oskarsson HJ, Minor RL, Lopez JAG, Winniford MD. Acute effect of cigarette smoking on the coronary circulation: constriction of epicardial and resistance vessels. J Am Coll Cardiol. 1993;22:642-647.
29. Minor RL, Oskarsson H, Quillen JE, Rossen JD, Winniford MD. Intracoronary phentolamine reverses cigarette smoking-induced vasoconstriction of coronary resistance vessels in humans. Circulation. 1992;86(suppl I):I-854. Abstract.
30. Penn A, Snyder CA. Inhalation of sidestream cigarette smoke accelerates development of arteriosclerotic plaques. Circulation. 1993;88:1820-1825.
31. Zhu B-Q, Sun Y-P, Sievers RE, Isenberg WM, Glantz SA, Parmley WW. Passive smoking increases atherosclerosis in cholesterol-fed rabbits. J Am Coll Cardiol. 1993;21:225-232.
32. Asmussen I, Kjeldsen K. Intimal ultrastructure of human umbilical arteries: observations on arteries from newborn children of smoking and nonsmoking mothers. Circ Res. 1975;36:579-589.
33. Davis JW, Shelton L, Eigenberg DA, Hignite CE, Watanabe IS. Effects of tobacco and non-tobacco cigarette smoking on endothelium and platelets. Clin Pharmacol Ther. 1985;37:529-533.
34. Kannel WB, D'Agostino RB, Belanger AJ. Fibrinogen, cigarette smoking, and risk of cardiovascular disease: insights from the Framingham study. Am Heart J. 1987;113:1006-1010.
35. 2 and prostacyclin metabolites in young men. Circulation. 1991;83:1698-1704.
36. Kimura S, Nishinaga M, Ozawa T, Shimada K. Thrombin generation as an acute effect of cigarette smoking. Am Heart J. 1994; 128:7-11.
37. Murohara T, Kygiyama K, Ohgushi M, Sugiyama S, Yasue H. Cigarette smoke extract contracts isolated coronary porcine arteries by superoxide anion-mediated degradation of EDRF. Am J Physiol. 1994;266:H874-H880.
38. Ohara Y, Peterson TE, Harrison DG. Hypercholesterolemia increases endothelial superoxide anion production. J Clin Invest. 1993;91:2546-2551.
39. Chow CK, Thacker RR, Changchit C, Bridges RB, Rehm SR, Humble J, Turbek J. Lower levels of vitamin C and carotenes in plasma of cigarette smokers. J Am Coll Nutr. 1986;5:305-312.
40. Duthie GG, Wahle KJ. Smoking, antioxidants, essential fatty acids and coronary heart disease. Biochem Soc Trans. 1990;18:1051-1054.
41. Flavahan NA. Atherosclerosis or liprotein-induced endothelial dysfunction: potential mechanisms underlying reduction in EDRF/ nitric oxide activity. Circulation. 1992;85:1927-1938.
42. 2-isoprostanes) in plasma and low density lipoprotein exposed to oxidative stress in vitro. J Clin Invest. 1994;93:998-1004.
43. Parthasarathy S, Steinberg D, Witztum JL. The role of oxidized low-density lipoproteins in the pathogenesis of atherosclerosis. Annu Rev Med. 1992;43:219-225.
44. Regnström J, Nilsson J, Tornvall P, Landou C, Hamsten A. Susceptibility to low-density lipoprotein oxidation and coronary atherosclerosis in man. Lancet. 1992;339:1183-1186.
45. Maggi E, Chiesa R, Melissano G, Castellano R, Astore D, Grossi A, Finardi G, Bellomo G. LDL oxidation in patients with severe carotid atherosclerosis: a study of in vitro and vivo oxidation markers. Arterioscler Thromb. 1994;14:1892-1899.